X4 Pharmaceuticals SG&A Expense (Quarterly) Analysis

X4 Pharmaceuticals Inc (XFOR)

1.015 +0.04 (+4.01%) USD | NASDAQ | May 31, 16:00

1.02 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2016. Upgrade now.

Date	Value
March 31, 2024	17.44M
December 31, 2023	9.927M
September 30, 2023	8.133M
June 30, 2023	10.20M
March 31, 2023	7.241M
December 31, 2022	6.563M
September 30, 2022	6.044M
June 30, 2022	6.749M
March 31, 2022	7.664M
December 31, 2021	7.135M
September 30, 2021	5.931M
June 30, 2021	5.804M
March 31, 2021	5.832M
December 31, 2020	5.357M
September 30, 2020	5.599M

Date	Value
June 30, 2020	5.316M
March 31, 2020	4.67M
December 31, 2019	3.914M
September 30, 2019	4.383M
June 30, 2019	4.56M
March 31, 2019	4.783M
December 31, 2018	-1.039M
September 30, 2018	3.275M
June 30, 2018	3.686M
March 31, 2018	2.817M
December 31, 2017	2.376M
September 30, 2017	2.455M
June 30, 2017	1.738M
March 31, 2017	1.436M
December 31, 2016	1.473M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

3.914M

Minimum

Dec 2019

17.44M

Maximum

Mar 2024

6.923M

Average

5.988M

Median

SG&A Expense (Quarterly) Benchmarks